7-94545647-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022900.5(CASD1):āc.1579G>Cā(p.Val527Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,609,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022900.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CASD1 | NM_022900.5 | c.1579G>C | p.Val527Leu | missense_variant | 12/18 | ENST00000297273.9 | |
LOC105375404 | XR_007060433.1 | n.74+12775C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CASD1 | ENST00000297273.9 | c.1579G>C | p.Val527Leu | missense_variant | 12/18 | 1 | NM_022900.5 | P1 | |
SGCE | ENST00000645624.1 | n.834-21374C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151790Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250332Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135380
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1457554Hom.: 0 Cov.: 31 AF XY: 0.0000262 AC XY: 19AN XY: 725176
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151908Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.1579G>C (p.V527L) alteration is located in exon 12 (coding exon 12) of the CASD1 gene. This alteration results from a G to C substitution at nucleotide position 1579, causing the valine (V) at amino acid position 527 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at